Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |